Value of Absolute Eosinophil Count in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention

References

• Aboyans V, Causes of Death Collaborators. Global, regional, and national age–sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;385(9963):117–171. doi:10.1016/S0140-6736(14)61682-2
   PubMed Web of Science ®Google Scholar
• Madjid M, Awan I, Willerson JT, et al. Leukocyte count and coronary heart disease: implications for risk assessment. J Am Coll Cardiol. 2004;44(10):1945–1956. doi:10.1016/j.jacc.2004.07.056
   PubMed Web of Science ®Google Scholar
• Toor IS, Jaumdally R, Lip GY, et al. Eosinophil count predicts mortality following percutaneous coronary intervention. Thromb Res. 2012;130(4):607–611. doi:10.1016/j.thromres.2012.05.033
   PubMed Web of Science ®Google Scholar
• Zhao X, Jiang L, Xu L, et al. Predictive value of in-hospital white blood cell count in Chinese patients with triple-vessel coronary disease. Eur J Prev Cardiol. 2019;26(8):872–882. doi:10.1177/2047487319826398
   PubMed Web of Science ®Google Scholar
• Hayiroğlu M, Çinar T, Çinier G, et al. Evaluating systemic immune-inflammation index in patients with implantable cardioverter defibrillator for heart failure with reduced ejection fraction. Pacing Clin Electrophysiol. 2022;45(2):188–195. doi:10.1111/pace.14436
   PubMed Web of Science ®Google Scholar
• Şaylik F, Çinar T, Selçuk M, et al. Evaluation of Naples Score for Long-Term Mortality in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention. Angiology;2023. 33197231170982. doi:10.1177/00033197231170982
   PubMedGoogle Scholar
• Toor I, Ruckerl D, Mair I, et al. Eosinophil Deficiency Promotes Aberrant Repair and Adverse Remodeling Following Acute Myocardial Infarction. JACC Basic Transl Sci. 2020;5(7):665–681. doi:10.1016/j.jacbts.2020.05.005
   PubMedGoogle Scholar
• Xu J, Xiong Y, Tang R, et al. Interleukin-5-induced eosinophil population improves cardiac function after myocardial infarction. Cardiovascular Res. 2021;118(9):2165–2178. doi:10.1093/cvr/cvab237
   Web of Science ®Google Scholar
• Kounis NG. Coronary hypersensitivity disorder: the Kounis syndrome. Clin Ther. 2013;35(5):563–571. doi:10.1016/j.clinthera.2013.02.022
   PubMed Web of Science ®Google Scholar
• Umemoto S, Suzuki N, Fujii K, et al. Eosinophil counts and plasma fibrinogen in patients with vasospastic angina pectoris. Am J Cardiol. 2000;85(6):715–719. doi:10.1016/S0002-9149(99)00846-2
   PubMed Web of Science ®Google Scholar
• Novotny J, Oberdieck P, Titova A, et al. Thrombus NET content is associated with clinical outcome in stroke and myocardial infarction. Neurology. 2020;94(22):e2346–e60. doi:10.1212/WNL.0000000000009532
   PubMed Web of Science ®Google Scholar
• Groot H, Van Blokland I, Lipsic E, et al. Leukocyte profiles across the cardiovascular disease continuum: a population-based cohort study. J Mol Cell Cardiol. 2020;138:158–164. doi:10.1016/j.yjmcc.2019.11.156
   PubMed Web of Science ®Google Scholar
• Sasmita B, Zhu Y, Gan H, et al. Leukocyte and its Subtypes as Predictors of Short-Term Outcome in Cardiogenic Shock Complicating Acute Myocardial Infarction: a Cohort Study. Shock. 2022;57(3):351–359. doi:10.1097/SHK.0000000000001876
   PubMed Web of Science ®Google Scholar
• Gudbjartsson D, Bjornsdottir D, Halapi E, et al. Sequence variants affecting eosinophil numbers associate with asthma and myocardial infarction. Nat Genet. 2009;41(3):342–347. doi:10.1038/ng.323
   PubMed Web of Science ®Google Scholar
• S G, Deng Y, Wu J, et al. Eosinophils count in peripheral circulation is associated with coronary artery disease. Atherosclerosis. 2019;286:128–134. doi:10.1016/j.atherosclerosis.2019.05.027
   PubMed Web of Science ®Google Scholar
• Kounis N, Soufras G, Tsigkas G, et al. White blood cell counts, leukocyte ratios, and eosinophils as inflammatory markers in patients with coronary artery disease. Clin Appl Thromb Hemost. 2015;21(2):139–143. doi:10.1177/1076029614531449
   PubMed Web of Science ®Google Scholar
• Zabojszcz M, Januszek R, Siudak Z, et al. Association between the mortality rate and operator volume in patients undergoing emergency or elective percutaneous coronary interventions. Kardiologia polska. 2020;78(2):138–146. doi:10.33963/KP.15123
   PubMed Web of Science ®Google Scholar
• Young J, Peterson C, Venge P, et al. Mechanism of membrane damage mediated by human eosinophil cationic protein. Nature. 1986;321(6070):613–616. doi:10.1038/321613a0
   PubMed Web of Science ®Google Scholar
• Acharya K, Ackerman S. Eosinophil Granule Proteins: form and Function. J Biol Chem. 2014;289(25):17406–17415. doi:10.1074/jbc.R113.546218
   PubMed Web of Science ®Google Scholar
• Chihara J, Yamamoto T, Kayaba H. Degranulation of eosinophils mediated by intercellular adhesion molecule-1 and its ligands is involved in adhesion molecule expression on endothelial cells–selective induction of VCAM-1. J Allergy Clin Immunol. 1999;103(5 Pt 2):S452–6. doi:10.1016/S0091-6749(99)70161-2
   PubMed Web of Science ®Google Scholar
• Hogan S, Rosenberg H, Moqbel R, et al. Eosinophils: biological properties and role in health and disease. Clin Exp Allergy. 2008;38(5):709–750. doi:10.1111/j.1365-2222.2008.02958.x
   PubMed Web of Science ®Google Scholar
• Verdoia M, Schaffer A, Cassetti E. Absolute eosinophils count and the extent of coronary artery disease: a single centre cohort study. J Thromb Thrombolysis. 2015;39(4):459–466. doi:10.1007/s11239-014-1120-3
   PubMed Web of Science ®Google Scholar
• Virmani R, Guagliumi G, Farb A, et al. Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: should we be cautious? Circulation. 2004;109(6):701–705. doi:10.1161/01.CIR.0000116202.41966.D4
   PubMed Web of Science ®Google Scholar
• Joner M, Finn A, Farb A, et al. Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. J Am Coll Cardiol. 2006;48(1):193–202. doi:10.1016/j.jacc.2006.03.042
   PubMed Web of Science ®Google Scholar
• Finn A, Nakazawa G, Joner M, et al. Vascular responses to drug eluting stents: importance of delayed healing. Arterioscler Thromb Vasc Biol. 2007;27(7):1500–1510. doi:10.1161/ATVBAHA.107.144220
   PubMed Web of Science ®Google Scholar
• Ribichini F, Joner M, Ferrero V, et al. Effects of oral prednisone after stenting in a rabbit model of established atherosclerosis. J Am Coll Cardiol. 2007;50(2):176–185. doi:10.1016/j.jacc.2007.03.031
   PubMed Web of Science ®Google Scholar
• Niccoli G, Schiavino D, Belloni F, et al. Pre-intervention eosinophil cationic protein serum levels predict clinical outcomes following implantation of drug-eluting stents. Eur Heart J. 2009;30(11):1340–1347. doi:10.1093/eurheartj/ehp120
   PubMed Web of Science ®Google Scholar
• Park S-J, J-M A, Kim Y-H, et al. Trial of Everolimus-Eluting Stents or Bypass Surgery for Coronary Disease. N Engl J Med. 2015;372(13):1204–1212. doi:10.1056/NEJMoa1415447
   PubMed Web of Science ®Google Scholar
• Serruys P, Morice M-C, Kappetein A, et al. Percutaneous Coronary Intervention versus Coronary-Artery Bypass Grafting for Severe Coronary Artery Disease. N Engl J Med. 2009;360(10):961–972. doi:10.1056/NEJMoa0804626
   PubMed Web of Science ®Google Scholar
• Neumann F, Sousa-Uva M, Ahlsson A, et al. 2018 ESC/EACTS Guidelines on myocardial revascularization. Eur Heart J. 2019;40(2):87–165. doi:10.1093/eurheartj/ehy394
   PubMed Web of Science ®Google Scholar
• Tam D, Ruel M, Fremes S. Commentary: does the SYNTAX (Synergy between PCI with Taxus and Cardiac Surgery) score even matter? J Thorac Cardiovasc Surg. 2021.
   Web of Science ®Google Scholar
• Banning A, Serruys P, De Maria A, et al. Five-year outcomes after state-of-The-art percutaneous coronary revascularization in patients with de novo three-vessel disease: final results of the SYNTAX II study. Eur Heart J. 2022;43(13):1307–1316. doi:10.1093/eurheartj/ehab703
   PubMed Web of Science ®Google Scholar
• Hayiroglu M, Keskin M, Uzun AO, et al. Predictive value of SYNTAX score II for clinical outcomes in cardiogenic shock underwent primary percutaneous coronary intervention; a pilot study. Int J Cardiovasc Imaging. 2018;34(3):329–336. doi:10.1007/s10554-017-1241-9
   PubMed Web of Science ®Google Scholar
• Horne B, May H, Muhlestein J, et al. Exceptional mortality prediction by risk scores from common laboratory tests. Am j Med. 2009;122(6):550–558. doi:10.1016/j.amjmed.2008.10.043
   PubMed Web of Science ®Google Scholar
• Çinar T, Şaylik F, Akbulut T, et al. Evaluation of Intermountain Risk Score for Short- and Long-Term Mortality in ST Elevation Myocardial Infarction Patients. Angiology. 2023;74(4):357–364. doi:10.1177/00033197221105753
   PubMed Web of Science ®Google Scholar
• Mert Ilker H, Faysal S, Ahmet Çağdaş Y, et al. Prognostic value of Intermountain Risk Score for short- and long-term mortality in patients with cardiogenic shock. Coronary Artery Disease. 2023;34(2):154–159. doi:10.1097/MCA.0000000000001219
   PubMed Web of Science ®Google Scholar